Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Takeda discloses natural ET receptor antagonist

Nov. 29, 1996

Takeda describes antiprotozoal agents

Nov. 29, 1996

New bombesin analogues from Biomeasure

Nov. 29, 1996

Merck & Co. describes new compounds for dopamine-related disorders

Nov. 29, 1996

NEP inhibitors claimed by Santen

Nov. 28, 1996

Natural farnesyltransferase inhibitors from Kitasato Institute

Nov. 28, 1996

Natural antiplatelet agent discovered at Kitasato Institute

Nov. 28, 1996

Reversible cysteine protease inhibitors reported by Arris

Nov. 28, 1996

PDE IV inhibitors reported by E. Merck

Nov. 28, 1996

New antibacterial agents under study at Bayer

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...